We are live on ! Find out more
CRL icon

Charles River Laboratories
CRL

644 hedge funds and large institutions have $13.5B invested in Charles River Laboratories in 2022 Q1 according to their latest regulatory filings, with 60 funds opening new positions, 262 increasing their positions, 235 reducing their positions, and 115 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more repeat investments, than reductions

Existing positions increased: 262 | Existing positions reduced: 235

0.8% more ownership

Funds ownership: 93.47% → 94.28% (+0.8%)

1% less call options, than puts

Call options by funds: $77.7M | Put options by funds: $78.4M

9% less funds holding

Funds holding: 707 → 644 (-63)

24% less capital invested

Capital invested by funds: $17.7B → $13.5B (-$4.23B)

48% less first-time investments, than exits

New positions opened: 60 | Existing positions closed: 115

53% less funds holding in top 10

Funds holding in top 10: 15 → 7 (-8)

Holders
644
Holders Change
-63
Holders Change %
-8.91%
% of All Funds
10.16%
Holding in Top 10
7
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-53.33%
% of All Funds
0.11%
New
60
Increased
262
Reduced
235
Closed
115
Calls
$77.7M
Puts
$78.4M
Net Calls
-$664K
Net Calls Change
-$48.1M

Top Buyers

1
Mackenzie Financial
Mackenzie Financial
Ontario, Canada
+$171M
2
ClearBridge Investments
ClearBridge Investments
New York
+$92.9M
3
Fidelity International
Fidelity International
Bermuda
+$83.3M
4
Two Sigma Investments
Two Sigma Investments
New York
+$53.3M
5
JMPWA
JP Morgan Private Wealth Advisors
California
+$47M

Top Sellers

1
Invesco
Invesco
Georgia
-$142M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$118M
3
Brown Advisory
Brown Advisory
Maryland
-$111M
4
Marshall Wace
Marshall Wace
United Kingdom
-$86.9M
5
ESCM
Echo Street Capital Management
New York
-$65.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
VF
701
Virtu Financial
New York
– -$272K -722 Closed
RMCM
702
Reynders McVeigh Capital Management
Massachusetts
– -$264K -700 Closed
GBT
703
Grove Bank & Trust
Florida
– -$256K -680 Closed
CAM
704
Cresset Asset Management
Illinois
– -$250K -666 Closed
IFS
705
Ifrah Financial Services
Arkansas
– -$249K -661 Closed
AC
706
ASB Consultores
Florida
– -$245K -651 Closed
CC
707
Chicago Capital
Illinois
– -$241K -640 Closed
PCM
708
Presidio Capital Management
California
– -$240K -637 Closed
ML
709
Mayport LLC
Massachusetts
– -$239K -635 Closed
FEM
710
Fulcrum Equity Management
Texas
– -$237K -629 Closed
VAFP
711
Vahanian & Associates Financial Planning
New York
– -$233K -619 Closed
Fayez Sarofim & Co
712
Fayez Sarofim & Co
Texas
– -$231K -612 Closed
AWM
713
AE Wealth Management
Kansas
– -$230K -611 Closed
HSA
714
HBK Sorce Advisory
Pennsylvania
– -$230K -610 Closed
OIA
715
OneDigital Investment Advisors
Kansas
– -$227K -602 Closed
EWM
716
Edge Wealth Management
New York
– -$226K -600 Closed
PWPS
717
Pinnacle Wealth Planning Services
Ohio
– -$225K -597 Closed
MYAM
718
Meiji Yasuda Asset Management
Japan
– -$222K -590 Closed
SAM
719
Silvercrest Asset Management
New York
– -$222K -590 Closed
V
720
Veritable
Delaware
– -$221K -586 Closed
DAS
721
Dynamic Advisor Solutions
Arizona
– -$219K -581 Closed
PSUF
722
People's United Financial
Connecticut
– -$217K -576 Closed
CC
723
Cypress Capital
Tennessee
– -$211K -560 Closed
VVP
724
Venture Visionary Partners
Ohio
– -$208K -553 Closed
NPP
725
New Potomac Partners
Maryland
– -$207K -550 Closed
27 28
29
30 31

CRL Hedge Fund Activity: Q1 2022 in Review

644 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q1 2022, worth a combined $13.5B — down 24% from $17.7B a quarter earlier.

Sellers outnumbered buyers: 115 funds closed out of CRL and 60 opened new positions — a net loss of 55 holders — while 235 trimmed existing stakes and 262 added.

The largest buyer was Mackenzie Financial, adding an estimated $171M. The largest seller was Invesco, cutting an estimated $142M.

  • 644 institutional investors held Charles River Laboratories (CRL) as of Q1 2022, down from 707 in Q4 2021.
  • Funds reported $13.5B of Charles River Laboratories stock for Q1 2022, down 24% quarter-over-quarter.
  • 60 funds opened new Charles River Laboratories positions in Q1 2022 and 115 closed out, a net change of -55 holders.
  • The largest Charles River Laboratories buyer in Q1 2022 was Mackenzie Financial, an estimated $171M added.
  • The largest Charles River Laboratories seller in Q1 2022 was Invesco, an estimated $142M sold.

Based on aggregated 13F filings for Q1 2022.